FAS and neoplasm: In the current study, we further defined the mechanisms involved in B cell-mediated killing of tumor cells and found that activated B effector cells killed tumor involving the CXCR4/CXCL12 and perforin pathways as well as the Fas/FasL interaction, and can be augmented by IL-2.